Skip to content

Single-Arm Clinical Study of Shen Ling Jiang Tang Formula in treating Type 2 Diabetes Mellitus

Single-Arm Clinical Study of Shen Ling Jiang Tang Formula in treating Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068090
Enrollment
Unknown
Registered
2023-02-07
Start date
2023-02-07
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Treatment:Oral Shen Ling Jiang Tang Formula

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-75, gender unlimited; 2. Consistent with the TCM syndrome diagnostic criteria of internal injury with hidden pathogen and accumulation of phlegm-heat-wind-fluid; 3. Meeting the 1999 WHO diagnostic criteria for type 2 diabetes; 4. Voluntary subjects who understand and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute complications of diabetes, such as diabetic ketosis, hypertonic coma, etc.; 2. Confirmed diabetic renal disease in stage III to ?, or other renal diseases with moderate or higher risk of progression; 3. Patients with acute central nervous system diseases, severe gastrointestinal diseases, history of HIV infection, history of mental illness, history of malignant tumors; 4. Complicated with serious diseases and dysfunction of other organs, and complicated with life-threatening complications such as severe infection; 5. Pregnant or lactating women; 6. Known allergy to these drug ingredients.

Design outcomes

Primary

MeasureTime frame
Blood Glucose;

Secondary

MeasureTime frame
TCM syndrome scores;Insulin;C-Peptide;Glycosylated Hemoglobin A1c;Total Cholesterol;Triglyceride;High Density Lipoprotein;Low Density Lipoprotein;

Countries

China

Contacts

Public ContactLiu Weijing

Dongzhimen Hospital, Beijing University of Chinese Medicine

liuweijing-1977@hotmail.com13522609516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026